The polysaccharide Pullulan improves the initial steps of allergen-specific immunotherapy in dogs.
Clinical evidence update from The Veterinary record
Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in The Veterinary record in 2026 evaluated the polysaccharide Pullulan improves the initial steps of allergen-specific immunotherapy in dogs..
Key Findings
Allergen-specific immunotherapy (AIT) is the only aetiological treatment for canine atopic dermatitis (CAD). Pullulan, a polysaccharide with immunomodulatory properties, may enhance AIT outcomes when combined with allergens such as recombinant Dermatophagoides farinae 2 (Der f 2). This study evaluated the safety and efficacy of Pullulan-adjuvanted AIT using recombinant Der f 2 or D. farinae (DF) extracts compared with conventional DF extract immunotherapy. In this prospective, randomised study, 30 client-owned CAD dogs sensitised to DF were assigned to receive either subcutaneous immunotherapy (SCIT) with DF, SCIT with DF plus Pullulan...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
Comments
Related Articles
Copyright © 2026 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment